(Q51483374)
Statements
1 reference
Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial. (English)
1 reference
Julio Rosenstock
1 reference
Barry J Goldstein
1 reference
Deborah Anzalone
1 reference
Conrad Tou
1 reference
K Peter Ohman
1 reference
1 December 2006
1 reference
22
1 reference
12
1 reference
2575-2590
1 reference
Identifiers
1 reference